Aroa Biosurgery Limited (ASX:ARX)

Aroa Biosurgery Income Statement

Financials in millions NZD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	84.7	69.07	63.36	39.68	22.34
Revenue Growth (YoY)	22.63%	9.01%	59.68%	77.60%	-10.90%
Cost of Revenue	12.08	10.09	9.88	9.38	6.82
Gross Profit	72.61	58.97	53.48	30.3	15.52
Selling, General & Admin	67.05	62.15	47.71	30.71	21.76
Research & Development	9.57	9.16	10.61	8.35	6.43
Other Operating Expenses	-1.08	-1.66	-1.73	-1.12	-2.68
Operating Expenses	75.53	69.64	56.59	37.95	25.5
Operating Income	-2.92	-10.67	-3.11	-7.64	-9.98
Interest Expense	-0.48	-0.49	-0.38	-1.15	-1.91
Interest & Investment Income	1.06	1.8	1.32	0.4	0.15
Currency Exchange Gain (Loss)	-0.9	-1.05	1.8	0.13	0.65
Other Non Operating Income (Expenses)	-0.01	-0.01	-0.01	-0	-0
EBT Excluding Unusual Items	-3.25	-10.43	-0.38	-8.26	-11.09
Other Unusual Items	-	-	-	-	-8.01
Pretax Income	-3.25	-10.43	-0.38	-8.26	-19.1
Income Tax Expense	0.56	0.2	0.01	0.13	0.11
Net Income	-3.81	-10.63	-0.4	-8.39	-19.21
Net Income to Common	-3.81	-10.63	-0.4	-8.39	-19.21
Shares Outstanding (Basic)	345	344	343	342	300
Shares Outstanding (Diluted)	345	344	343	342	300
Shares Change (YoY)	0.31%	0.27%	0.22%	13.90%	10620.95%
EPS (Basic)	-0.01	-0.03	-0.00	-0.02	-0.06
EPS (Diluted)	-0.01	-0.03	-0.00	-0.02	-0.06
Free Cash Flow	-4.88	-10.9	-9.8	-15.98	-6.27
Free Cash Flow Per Share	-0.01	-0.03	-0.03	-0.05	-0.02
Gross Margin	85.73%	85.39%	84.40%	76.37%	69.48%
Operating Margin	-3.45%	-15.45%	-4.91%	-19.26%	-44.66%
Profit Margin	-4.50%	-15.39%	-0.63%	-21.13%	-85.98%
Free Cash Flow Margin	-5.76%	-15.78%	-15.47%	-40.27%	-28.07%
EBITDA	0.26	-7.4	-0.08	-5.29	-7.67
EBITDA Margin	0.30%	-10.71%	-0.13%	-13.32%	-34.33%
D&A For EBITDA	3.17	3.28	3.03	2.36	2.31
EBIT	-2.92	-10.67	-3.11	-7.64	-9.98
EBIT Margin	-3.45%	-15.45%	-4.91%	-19.26%	-44.66%

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.